# Ep. 119 Single-Gene NIPT Explained: Clinical Applications & Benefits with Dr. Andrei Rebarber

Page: https://stenobird.com/podcast/backtable-women-s-health-5805654/ep-119-single-gene-nipt-explained-clinical-applications-benefits-with-dr-andrei-rebarber
Text version: https://stenobird.com/podcast/backtable-women-s-health-5805654/ep-119-single-gene-nipt-explained-clinical-applications-benefits-with-dr-andrei-rebarber.md
Podcast: [BackTable Women's Health](https://stenobird.com/podcast/backtable-women-s-health-5805654)
Published: 2026-06-02T07:00:00+00:00
Episode link: https://traffic.megaphone.fm/BTL1058292618.mp3
Audio file: https://traffic.megaphone.fm/BTL1058292618.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/backtable-women-s-health-5805654/episodes/ep-119-single-gene-nipt-explained-clinical-applications-benefits-with-dr-andrei-rebarber
Duration seconds: 2553

## Resource

How do you decide which noninvasive prenatal testing option is best for your patient, and when should you reach for single-gene NIPT? In this episode of BackTable Women’s Health, host Dr. Nicole Faulkner interviews maternal-fetal medicine specialist Dr. Andrei Rebarber to break down the evolving world of prenatal genetic testing. They discuss the importance of pan-ethnic carrier screening, the clinical scenarios where single-gene NIPT is most useful, and how to navigate counseling and follow-up for a wide range of patients. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by Naterahttps://www.natera.com/info/fetal-focus --- Timestamps 00:00 - Introduction04:43 - Prenatal Genetic Testing Basics07:10 - Larger Panel Screening Benefits10:49 - Defining Single-Gene NIPT14:51 - Counseling and Invasive Options18:26 - Accuracy Data and No Call Rate22:03 - Patient Acceptance of Test24:18 - When to Test and Screen26:13 - Counseling Carrier Results30:12 - In Utero Treatment 32:36 - Workflow for Generalists35:33 - How to Interpret Literature40:08 - Closing Remarks --- More about this episode Dr. Rebarber shares how witnessing in-utero transfusions for severe Rh disease inspired his career in OBGYN and maternal-fetal medicine, highlighting the importance of treating the fetus as a patient and the rapid growth of fetal therapy. The episode reviews ACOG-guided carrier screening for conditions like cystic fibrosis and hemoglobinopathies, the trend toward larger, pan-ethnic screening panels, and why carrier findings are common but true “double-carrier” couples are relatively rare. Dr. Rebarber also discusses the clinical utility of single-gene NIPT—a cell-free placental DNA test for select recessive conditions—especially when partner testing isn’t pos…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/backtable-women-s-health-5805654/episodes/ep-119-single-gene-nipt-explained-clinical-applications-benefits-with-dr-andrei-rebarber/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/backtable-women-s-health-5805654/ep-119-single-gene-nipt-explained-clinical-applications-benefits-with-dr-andrei-rebarber.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.